Chongqing Genrix Biopharmaceutical Co (SHSE:688443) OCF Margin %: -245.96% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688443 Chongqing Genrix Biopharmaceutical Co Ltd SHSE:688443
43 GF Score
Price ¥25.12
! 4 Warning Signs
View Full Analysis

What is Chongqing Genrix Biopharmaceutical Co OCF Margin %?

Chongqing Genrix Biopharmaceutical Co SHSE:688443 +1.17% 43 OCF Margin % is -245.96% as of Mar. 2026. GuruFocus rates SHSE:688443 with a GF Score™ of 43/100. The stock has 4 warning signs investors should review. Among 950 Biotechnology companies, Chongqing Genrix Biopharmaceutical Co ranks worse than 58.32% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Chongqing Genrix Biopharmaceutical Co's Cash Flow from Operations for the three months ended in Mar. 2026 was ¥-165.4 Mil. Chongqing Genrix Biopharmaceutical Co's Revenue for the three months ended in Mar. 2026 was ¥67.2 Mil. Therefore, Chongqing Genrix Biopharmaceutical Co's OCF Margin % for the quarter that ended in Mar. 2026 was -245.96%.

As of today, Chongqing Genrix Biopharmaceutical Co's current OCF Yield % is -4.26%.

The historical rank and industry rank for Chongqing Genrix Biopharmaceutical Co's OCF Margin % or its related term are showing as below:

SHSE:688443' s OCF Margin % Range Over the Past 10 Years
Min: -422980.65   Med: -12903.68   Max: -146.45
Current: -141.32

During the past 7 years, the highest OCF Margin % of Chongqing Genrix Biopharmaceutical Co was -146.45%. The lowest was -422980.65%. And the median was -12903.68%.

SHSE:688443's OCF Margin % is ranked worse than
58.32% of 950 companies
in the Biotechnology industry
Industry Median: -64.565 vs SHSE:688443: -141.32

Chongqing Genrix Biopharmaceutical Co OCF Margin % Related Terms

Chongqing Genrix Biopharmaceutical Co OCF Margin % Historical Data

* Premium members only.

The historical data trend for Chongqing Genrix Biopharmaceutical Co's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chongqing Genrix Biopharmaceutical Co OCF Margin % Chart

Chongqing Genrix Biopharmaceutical Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial -606.85 -37,398.11 -31,153.55 -1,912.07 -146.45

Chongqing Genrix Biopharmaceutical Co Quarterly Data
Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -549.15 -21.30 -89.50 -331.06 -245.96

SHSE:688443 vs VRTX, REGN, ALNY: OCF Margin % Comparison

For the Biotechnology subindustry, Chongqing Genrix Biopharmaceutical Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chongqing Genrix Biopharmaceutical Co OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chongqing Genrix Biopharmaceutical Co's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Chongqing Genrix Biopharmaceutical Co's OCF Margin % falls into.


SHSE:688443
43GF Score
Chongqing Genrix Biopharmaceutical Co Ltd SHSE:688443
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chongqing Genrix Biopharmaceutical Co OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Chongqing Genrix Biopharmaceutical Co's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-337.905/230.727
=-146.45 %

Chongqing Genrix Biopharmaceutical Co's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-165.403/67.247
=-245.96 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -245.96% mean?
Chongqing Genrix Biopharmaceutical Co (SHSE:688443) has a OCF Margin % of -245.96% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Chongqing Genrix Biopharmaceutical Co and its competitors. According to the industry distribution chart, Chongqing Genrix Biopharmaceutical Co ranks #554 out of 950 companies in the Biotechnology industry, placing it in the top 58.3%.
Is Chongqing Genrix Biopharmaceutical Co's OCF Margin % too high?
Chongqing Genrix Biopharmaceutical Co's current OCF Margin % is -245.96%. Based on the distribution chart, Chongqing Genrix Biopharmaceutical Co ranks #554 out of 950 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Chongqing Genrix Biopharmaceutical Co has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Chongqing Genrix Biopharmaceutical Co's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Chongqing Genrix Biopharmaceutical Co ranks #554 out of 950 companies for OCF Margin %. This places Chongqing Genrix Biopharmaceutical Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Chongqing Genrix Biopharmaceutical Co and its competitors. Chongqing Genrix Biopharmaceutical Co's current OCF Margin % is -245.96%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chongqing Genrix Biopharmaceutical Co stock overvalued right now?
Chongqing Genrix Biopharmaceutical Co (SHSE:688443) has a current OCF Margin % of -245.96%. The current OCF Margin % is -245.96%. Chongqing Genrix Biopharmaceutical Co's overall GF Score™ is 43/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Chongqing Genrix Biopharmaceutical Co (SHSE:688443), the current OCF Margin % is -245.96% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Chongqing Genrix Biopharmaceutical Co Business Description

Address No. 699, Maliu Avenue, Area A, Building 2, International Bio City, Banan District, Chongqing, CHN, 401338
Chongqing Genrix Biopharmaceutical Co Ltd is a biopharmaceutical company engaged in the research & development, production and sales of antibody drugs. The company's pipeline includes product candidate that targets Autoimmune Diseases, Infectious Diseases, and Oncology.
43GF Score

Get the complete analysis for SHSE:688443

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥25.12
Price